检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:路航 Lu Hang(Luoyang Central Hospital,Luoyang,Henan 471000,China)
出 处:《现代临床医学》2024年第5期333-335,349,共4页Journal of Modern Clinical Medicine
摘 要:目的:分析左主干闭塞急诊经皮冠状动脉介入治疗(PCI)患者的临床特点。方法:收集2018年5月至2022年5月于我院接受急诊冠状动脉造影,并证实为左主干急性闭塞患者的临床资料,共21例,均行急诊PCI术,根据存活情况分为存活组(12例)和死亡组(9例),回顾性分析其临床特点及预后。结果:21例左主干闭塞患者病死率为42.85%。死亡组患者的肌酐和NT-proBNP水平高于存活组,发病至开通血管时间长于存活组(P<0.05)。存活组左主干植入支架率与术后冠状动脉血流恢复TIMI3级的比例高于死亡组(P<0.05)。结论:急诊PCI术为目前治疗左主干闭塞的有效手段,但术后病死率仍较高,其预后影响因素多,该病最佳治疗方案还需要进一步研究。Objective:To analyze the clinical characteristics of patients undergoing emergency percutaneous coronary intervention(PCI)for left main artery occlusion.Methods:From May 2018 to May 2022,the clinical data of 21 patients with acute occlusion of the left main artery confirmed by emergency coronary angiography in our hospital were collected.All patients underwent emergency PCI.According to the survival condition,they were divided into survival group(12 cases)and death group(9 cases).Their clinical characteristics and prognosis were retrospectively analyzed.Results:The case fatality of 21 patients with left main artery occlusion was 42.85%.The levels of creatinine and NT-proBNP in the death group were higher than those in the survival group,and the time from onset to vascular opening was longer than that in the survival group(P<0.05).The stent implantation rate and the proportion of postoperative coronary blood flow returning to TIMI perfusion grade 3 in the survival group was higher than that in the death group(P<0.05).Conclusion:Emergency PCI is an effective method for the treatment of left main artery occlusion at present,but its postoperative case fatality is stil high,and there are many factors affecting the prognosis.The optimal treatment of this disease still needs further study.
分 类 号:R542.4[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.49